Will Stratton

Mr. Stratton is Vice President, Corporate Development and Strategy at Autobahn Therapeutics

Mr. Stratton is an experienced leader in the life sciences industry with expertise in business development and strategy across the biotechnology, pharmaceutical, and medical technology sectors. Prior to Autobahn, Mr. Stratton served as the vice president, business development at Avelas Biosciences, where he provided leadership in areas of business and corporate development, financing, corporate strategy, and investor relations, as well as supported finance, operations, and administration functions. Mr. Stratton previously worked in global business and corporate development at Rakuten Medical, where he was primarily responsible for early-R&D business development activities. Prior to Rakuten Medical, Mr. Stratton held roles in business development and strategic planning at NAVICAN (now, Intermountain Precision Genomics). Mr. Stratton started his career in management consulting, where he advised life sciences clients in the areas of business development and commercial strategy. Mr. Stratton received an MBA with majors in healthcare management and entrepreneurial management from the Wharton School at the University of Pennsylvania and holds a B.S. in chemistry from Yale University.